Target intelligence / Profile preview

Multiple ubiquitous cellular components

Molecular classification
Other
01

Overview

The term Multiple ubiquitous cellular components is a non-specific classification used in pharmacological databases like ChEMBL to describe drugs that do not have a single, discrete molecular target [1]. Instead, these agents interact with a wide variety of cellular structures, including lipid membranes and numerous membrane-bound proteins, often simultaneously [2]. This category is most commonly associated with general anesthetics, such as halothane and isoflurane, which are believed to exert their effects by altering the physical properties of cell membranes or by non-specifically modulating various ion channels [3]. Other substances falling under this umbrella include certain antiseptics and solvents that cause broad chemical or physical disruption to cellular integrity [1]. Because this designation encompasses a vast array of biological molecules rather than a specific protein or receptor, it is not considered a therapeutic target in the traditional sense [1]. The lack of specificity inherent in drugs targeting these components often leads to complex pharmacological profiles and a higher risk of systemic side effects [3]. Consequently, this classification serves more as a catch-all for agents with multi-faceted or poorly defined mechanisms of action rather than a guide for targeted drug development [1]. Sources: [1] ChEMBL Database (Target ID: CHEMBL612111); [2] Franks, N. P. (2008). Nature Reviews Neuroscience; [3] Urban, B. W. (2002). British Journal of Anaesthesia.

Other names
Non-specific cellular targetsUbiquitous cellular elementsNon-specific targets
02

Mechanism of action

Non-specific modulation of lipid bilayer fluidity and multi-target interaction with various membrane-bound proteins and cellular structures [2][3].

03

Biological functions

Membrane stabilizationMembrane disruptionProtein denaturationOxidative stress
04

Disease associations

AnesthesiaInfection
05

Safety considerations

Systemic toxicityLack of selectivityNarrow therapeutic indexRespiratory depressionCardiovascular instability
06

Interacting drugs

Halothane

9 more in the full profile.

Beyond the preview

Go deeper on Multiple ubiquitous cellular components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple ubiquitous cellular components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call